Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in PAH with Angina
NCT01174173Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Jun 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranolazine in pulmonary arterial hypertension (PAH), angina pectoris, sponsored by Northwestern University. Started Jun 2010; status: completed.
02
Drugs
ranolazine
03
Conditions
pulmonary arterial hypertension (PAH)angina pectoris
Beyond the preview
Go deeper on NCT01174173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174173.